Neil F. McFarlane - Jan 31, 2025 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
President and CEO, Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Neil F. McFarlane
Stock symbol
ZVRA
Transactions as of
Jan 31, 2025
Transactions value $
$0
Form type
4
Date filed
2/3/2025, 05:19 PM
Previous filing
May 16, 2024
Next filing
Feb 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Options Exercise +233K +466.67% 283K Jan 31, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVRA Restricted Stock Unit Options Exercise $0 -233K -33.33% $0.00 467K Jan 31, 2025 Common Stock 233K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.